Mitochondrial Peptide Research — proposed research program

Proposed: not enrolling

Research question

Which experimental findings in mitochondrial-peptide research are reproducible, and which remain untested as clinical interventions?

Proposed scope

This proposed program would begin with evidence mapping and methods discussion around mitochondrial-derived peptides, including MOTS-c. It would separate endogenous measurements, administered peptides, and modified analogues. Findings from cells, animal experiments, and human observational work would be recorded as different evidence streams.

Methods to develop

A methods framework could identify the assay, sample type, timing, biological compartment, and endpoint behind a mitochondrial claim. Respiration, ATP production, exercise performance, and clinical function would remain distinct. The framework would also examine whether an assay measures the claimed entity and whether the proposed inference is supported by the experiment.

Scientific purpose

The initial value would be a transparent account of research gaps and priorities for reproducible collaboration. It would not characterize an observational biomarker association as proof that administering a peptide improves performance or extends human life. Any interventional study would require separate scientific justification, product characterization, and an approved protocol.

Current status

This is an editorial proposal for discussion, not an active study or approved registry. There is no enrollment and no patient-data collection. Investigators, sites, partners, funding, ethics approval, and study dates have not been established by this description. A protocol, ethics and data-protection review, and appropriate institutional authorization would be required before any research activity involving participants.

References informing the proposal

• Alberts B, Johnson A, Lewis J, et al. 2002. The mitochondria. Molecular Biology of the Cell, fourth edition. Garland Science. Reference chapter on organization and physiology.
• Alberts B, Johnson A, Lewis J, et al. 2002. Energy conversion in mitochondria and chloroplasts. Molecular Biology of the Cell, fourth edition. Garland Science. Reference chapter on coupling and energy production.
• Alberts B, Johnson A, Lewis J, et al. 2002. Protein transport to mitochondria and chloroplasts. Molecular Biology of the Cell, fourth edition. Garland Science. Reference chapter on synthesis and import.
• Narendra D, Tanaka A, Suen DF, et al. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008;183(5):795-803. DOI: 10.1083/jcb.200809125. PMID: 19029340.
• Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-54. DOI: 10.1016/j.cmet.2015.02.009. PMID: 25738459.